Share-based Payment Arrangement, Expense of LEMAITRE VASCULAR INC from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LEMAITRE VASCULAR INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • LEMAITRE VASCULAR INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,740,000, a 8.1% increase year-over-year.
  • LEMAITRE VASCULAR INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $7,469,000, a 20% increase year-over-year.
  • LEMAITRE VASCULAR INC annual Share-based Payment Arrangement, Expense for 2024 was $6,568,000, a 23% increase from 2023.
  • LEMAITRE VASCULAR INC annual Share-based Payment Arrangement, Expense for 2023 was $5,319,000, a 27% increase from 2022.
  • LEMAITRE VASCULAR INC annual Share-based Payment Arrangement, Expense for 2022 was $4,173,000, a 20% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

LEMAITRE VASCULAR INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,469,000 $1,740,000 +$130,000 +8.1% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $7,339,000 $1,944,000 +$335,000 +21% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $7,004,000 $2,046,000 +$436,000 +27% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $6,568,000 $1,739,000 +$335,000 +24% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q3 2024 $6,233,000 $1,610,000 +$297,000 +23% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $5,936,000 $1,609,000 +$297,000 +23% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $5,639,000 $1,610,000 +$320,000 +25% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $5,319,000 $1,404,000 +$720,000 +105% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $4,599,000 $1,313,000 +$127,000 +11% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $4,472,000 $1,312,000 +$176,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $4,296,000 $1,290,000 +$123,000 +11% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $4,173,000 $684,000 -$202,000 -23% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $4,375,000 $1,186,000 +$389,000 +49% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $3,986,000 $1,136,000 +$267,000 +31% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $3,719,000 $1,167,000 +$240,000 +26% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $3,479,000 $886,000 +$133,000 +18% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $3,346,000 $797,000 +$110,000 +16% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $3,236,000 $869,000 +$66,000 +8.2% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $3,170,000 $927,000 +$148,000 +19% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $3,022,000 $753,000 +$206,000 +38% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $2,816,000 $687,000 +$32,000 +4.9% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $2,784,000 $803,000 +$109,000 +16% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $2,675,000 $779,000 +$33,000 +4.4% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $2,642,000 $547,000 -$8,000 -1.4% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $2,650,000 $655,000 +$118,000 +22% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $2,532,000 $694,000 +$58,000 +9.1% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $2,474,000 $746,000 +$125,000 +20% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $2,349,000 $555,000 +$145,000 +35% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
Q3 2018 $2,204,000 $537,000 -$350,000 -39% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $2,554,000 $636,000 +$164,000 +35% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $2,390,000 $621,000 +$134,000 +28% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q4 2017 $2,256,000 $410,000 -$75,000 -15% 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
Q3 2017 $2,331,000 $887,000 +$354,000 +66% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $1,977,000 $472,000 +$140,000 +42% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 $1,837,000 $487,000 +$157,000 +48% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $1,680,000 $485,000 +$149,000 +44% 01 Oct 2016 31 Dec 2016 10-K 11 Mar 2019 2018 FY
Q3 2016 $1,531,000 $533,000 +$54,000 +11% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2017 Q3
Q2 2016 $1,477,000 $332,000 +$51,000 +18% 05 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $1,426,000 $330,000 +$2,000 +0.61% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q4 2015 $1,424,000 $336,000 01 Oct 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
Q3 2015 $479,000 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $281,000 04 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $328,000 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1

LEMAITRE VASCULAR INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,568,000 +$1,249,000 +23% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
2023 $5,319,000 +$1,146,000 +27% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 $4,173,000 +$694,000 +20% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $3,479,000 +$457,000 +15% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $3,022,000 +$380,000 +14% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $2,642,000 +$293,000 +12% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $2,349,000 +$93,000 +4.1% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
2017 $2,256,000 +$576,000 +34% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $1,680,000 +$256,000 +18% 01 Jan 2016 31 Dec 2016 10-K 11 Mar 2019 2018 FY
2015 $1,424,000 +$122,000 +9.4% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
2014 $1,302,000 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.